000 | 01873 a2200529 4500 | ||
---|---|---|---|
005 | 20250514060639.0 | ||
264 | 0 | _c20030328 | |
008 | 200303s 0 0 eng d | ||
022 | _a0013-7227 | ||
024 | 7 |
_a10.1210/en.2002-220926 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYoung, Morag J | |
245 | 0 | 0 |
_aEarly inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation. _h[electronic resource] |
260 |
_bEndocrinology _cMar 2003 |
||
300 |
_a1121-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _a11-beta-Hydroxysteroid Dehydrogenases |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCarbenoxolone _xpharmacology |
650 | 0 | 4 |
_aCardiomegaly _xenzymology |
650 | 0 | 4 |
_aCoronary Disease _xenzymology |
650 | 0 | 4 |
_aDesoxycorticosterone _xpharmacology |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aEplerenone |
650 | 0 | 4 | _aFibrosis |
650 | 0 | 4 |
_aHeart _xanatomy & histology |
650 | 0 | 4 |
_aHydroxysteroid Dehydrogenases _xantagonists & inhibitors |
650 | 0 | 4 |
_aKidney _xanatomy & histology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMineralocorticoid Receptor Antagonists |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xchemistry |
650 | 0 | 4 |
_aMyocardium _xpathology |
650 | 0 | 4 | _aNephrectomy |
650 | 0 | 4 |
_aOrgan Size _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aSodium Chloride _xadministration & dosage |
650 | 0 | 4 | _aSolutions |
650 | 0 | 4 |
_aSpironolactone _xanalogs & derivatives |
650 | 0 | 4 |
_aVasculitis _xenzymology |
700 | 1 | _aMoussa, Leon | |
700 | 1 | _aDilley, Rod | |
700 | 1 | _aFunder, John W | |
773 | 0 |
_tEndocrinology _gvol. 144 _gno. 3 _gp. 1121-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1210/en.2002-220926 _zAvailable from publisher's website |
999 |
_c12384117 _d12384117 |